Chronicle Journal: Finance

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Acadia Pharmaceutica (NQ: ACAD )

20.84 USD -0.18 (-0.86%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 11, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,038,903
Open 20.55
Bid (Size) 20.58 (1)
Ask (Size) 21.00 (1)
Prev. Close 21.02
Today's Range 20.36 - 21.60
52wk Range 19.20 - 58.72
Shares Outstanding 160,179,036
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acadia Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline – ACAD
From GlobeNewswire News Releases
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Acadia Pharmaceuticals (ACAD) Investors to Securities Class Action, Advises Investors with Losses to Contact Its Attorneys Now
From GlobeNewswire News Releases

Performance

YTD
-60.54%
-60.54%
1 Month
+2.01%
+2.01%
3 Month
-58.69%
-58.69%
6 Month
-57.48%
-57.48%
1 Year
-59.05%
-59.05%

More News

Read More
DEADLINE ALERT for FUV, EBS, ACAD, and CCIV: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
From GlobeNewswire News Releases
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Acadia Pharmaceuticals Inc. (ACAD)
From GlobeNewswire News Releases
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Intrusion, LifeMD, Romeo Power, and Acadia Pharmaceuticals and Encourages Investors to Contact the Firm
From GlobeNewswire News Releases
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Acadia Pharmaceuticals Inc. (ACAD) Investors
From PR Newswire
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Acadia Pharmaceuticals (ACAD) Investors to Securities Class Action and Application Deadline, Encourages Investors with Losses to Contact Its Attorneys N
From GlobeNewswire News Releases
Acadia Pharmaceuticals Reports First Quarter 2021 Financial Results
From Business Wire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acadia Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline - ACAD
From PR Newswire
SHAREHOLDER ALERT: Law Offices of Timothy L. Miles Is Investigating Acadia Pharmaceuticals Inc. on Behalf of Investors
Tags x:frankly s:tennessee healthcare/pharmaceuticals
From EIN Presswire
Acadia Pharmaceuticals to Present at Upcoming Investor Conferences
From Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]